Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of Neurosurgical Nursing|October 1, 1985
Neuroscience nursing elective for senior nursing studentsE L Barker
Molecular Pharmacology|October 1, 1993
5-hydroxytryptamine1C receptor density and mRNA levels in choroid plexus epithelial cells after treatment with mianserin and (-)-1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropaneE L Barker, E Sanders-Bush
Molecular Pharmacology|October 1, 1996
Identification of a single amino acid, phenylalanine 586, that is responsible for high affinity interactions of tricyclic antidepressants with the human serotonin transporterE L Barker, R D Blakely
The Journal of Pharmacology and Experimental Therapeutics|November 25, 2003
D2 dopamine receptors modulate Galpha-subunit coupling of the CB1 cannabinoid receptorA Jarrahian, V J Watts, E L Barker
Molecular Pharmacology|February 17, 2001
Interactions of tryptamine derivatives with serotonin transporter species variants implicate transmembrane domain I in substrate recognitionE M Adkins, E L Barker, R D Blakely
Brain Research|June 28, 1991
Phosphoinositide hydrolysis linked 5-HT2 receptors in fibroblasts from choroid plexusE L Barker, K D Burris, E Sanders-Bush
Molecular Pharmacology|November 1, 1994
Chimeric human and rat serotonin transporters reveal domains involved in recognition of transporter ligandsE L Barker, H L Kimmel, R D Blakely
Molecular Pharmacology|May 17, 2001
Role of fatty acid amide hydrolase in the transport of the endogenous cannabinoid anandamideT A Day, F Rakhshan, D G Deutsch, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 15, 1999
Transmembrane domain I contributes to the permeation pathway for serotonin and ions in the serotonin transporterE L Barker, K R Moore, F Rakhshan, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 25, 2000
Carrier-mediated uptake of the endogenous cannabinoid anandamide in RBL-2H3 cellsF Rakhshan, T A Day, R D Blakely, et al.
Pageof 2